172 related articles for article (PubMed ID: 10103184)
21. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.
Tsai CC; Emau P; Follis KE; Beck TW; Benveniste RE; Bischofberger N; Lifson JD; Morton WR
J Virol; 1998 May; 72(5):4265-73. PubMed ID: 9557716
[TBL] [Abstract][Full Text] [Related]
22. Effects of monotherapy with (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) on the evolution of a primary Simian immunodeficiency virus (SIV) isolate.
Taber R; Rajakumar PA; Fuller DH; Trichel AM; Dowling P; Meleason D; Amedee A; Murphey-Corb M
Virology; 2006 Oct; 354(1):116-31. PubMed ID: 16884757
[TBL] [Abstract][Full Text] [Related]
23. Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment.
Lifson JD; Rossio JL; Arnaout R; Li L; Parks TL; Schneider DK; Kiser RF; Coalter VJ; Walsh G; Imming RJ; Fisher B; Flynn BM; Bischofberger N; Piatak M; Hirsch VM; Nowak MA; Wodarz D
J Virol; 2000 Mar; 74(6):2584-93. PubMed ID: 10684272
[TBL] [Abstract][Full Text] [Related]
24. Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2.
Mattapallil JJ; Smit-McBride Z; Dailey P; Dandekar S
J Virol; 1999 Aug; 73(8):6661-9. PubMed ID: 10400763
[TBL] [Abstract][Full Text] [Related]
25. Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques.
Tsai CC; Follis KE; Beck TW; Sabo A; Bischofberger N; Dailey PJ
AIDS Res Hum Retroviruses; 1997 May; 13(8):707-12. PubMed ID: 9168239
[TBL] [Abstract][Full Text] [Related]
26. In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA.
Wainberg MA; Miller MD; Quan Y; Salomon H; Mulato AS; Lamy PD; Margot NA; Anton KE; Cherrington JM
Antivir Ther; 1999; 4(2):87-94. PubMed ID: 10682153
[TBL] [Abstract][Full Text] [Related]
27. Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques.
Van Rompay KK; Brignolo LL; Meyer DJ; Jerome C; Tarara R; Spinner A; Hamilton M; Hirst LL; Bennett DR; Canfield DR; Dearman TG; Von Morgenland W; Allen PC; Valverde C; Castillo AB; Martin RB; Samii VF; Bendele R; Desjardins J; Marthas ML; Pedersen NC; Bischofberger N
Antimicrob Agents Chemother; 2004 May; 48(5):1469-87. PubMed ID: 15105094
[TBL] [Abstract][Full Text] [Related]
28. Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.
Smith MS; Foresman L; Lopez GJ; Tsay J; Wodarz D; Lifson JD; Page A; Wang C; Li Z; Adany I; Buch S; Bischofberger N; Narayan O
Virology; 2000 Nov; 277(2):306-15. PubMed ID: 11080478
[TBL] [Abstract][Full Text] [Related]
29. PMPA beats SIV again.
GMHC Treat Issues; 1996 May; 10(5):8-9. PubMed ID: 11363586
[TBL] [Abstract][Full Text] [Related]
30. Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection.
Tsai CC; Emau P; Sun JC; Beck TW; Tran CA; Follis KE; Bischofberger N; Morton WR
J Med Primatol; 2000 Aug; 29(3-4):248-58. PubMed ID: 11085587
[TBL] [Abstract][Full Text] [Related]
31. Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status.
Villinger F; Brice GT; Mayne AE; Bostik P; Mori K; June CH; Ansari AA
Blood; 2002 Jan; 99(2):590-9. PubMed ID: 11781243
[TBL] [Abstract][Full Text] [Related]
32. The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy.
Clements JE; Li M; Gama L; Bullock B; Carruth LM; Mankowski JL; Zink MC
J Neurovirol; 2005 Apr; 11(2):180-9. PubMed ID: 16036796
[TBL] [Abstract][Full Text] [Related]
33. Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques.
Marthas ML; van Rompay KK; Otsyula M; Miller CJ; Canfield DR; Pedersen NC; McChesney MB
J Virol; 1995 Jul; 69(7):4198-205. PubMed ID: 7769679
[TBL] [Abstract][Full Text] [Related]
34. Administration of fludarabine-loaded autologous red blood cells in simian immunodeficiency virus-infected sooty mangabeys depletes pSTAT-1-expressing macrophages and delays the rebound of viremia after suspension of antiretroviral therapy.
Cervasi B; Paiardini M; Serafini S; Fraternale A; Menotta M; Engram J; Lawson B; Staprans SI; Piedimonte G; Perno CF; Silvestri G; Magnani M
J Virol; 2006 Nov; 80(21):10335-45. PubMed ID: 17041214
[TBL] [Abstract][Full Text] [Related]
35. Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus.
Van Rompay KK; Schmidt KA; Lawson JR; Singh R; Bischofberger N; Marthas ML
J Infect Dis; 2002 Nov; 186(10):1508-13. PubMed ID: 12404171
[TBL] [Abstract][Full Text] [Related]
36. A zidovudine-resistant simian immunodeficiency virus mutant with a Q151M mutation in reverse transcriptase causes AIDS in newborn macaques.
Van Rompay KK; Greenier JL; Marthas ML; Otsyula MG; Tarara RP; Miller CJ; Pedersen NC
Antimicrob Agents Chemother; 1997 Feb; 41(2):278-83. PubMed ID: 9021180
[TBL] [Abstract][Full Text] [Related]
37. Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults.
Deeks SG; Barditch-Crovo P; Lietman PS; Hwang F; Cundy KC; Rooney JF; Hellmann NS; Safrin S; Kahn JO
Antimicrob Agents Chemother; 1998 Sep; 42(9):2380-4. PubMed ID: 9736567
[TBL] [Abstract][Full Text] [Related]
38. Early treatment with 9-(2-phosphonylmethoxyethyl)adenine reduces virus burdens for a prolonged period in SIV-infected rhesus macaques.
Joag SV; Li Z; Foresman L; Pinson DM; Stephens EB; Raghavan R; Navé JF; Casara P; Narayan O
AIDS Res Hum Retroviruses; 1997 Feb; 13(3):241-6. PubMed ID: 9115811
[TBL] [Abstract][Full Text] [Related]
39. Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG.
Shen Y; Shen L; Sehgal P; Zhou D; Simon M; Miller M; Enimi EA; Henckler B; Chalifoux L; Sehgal N; Gastron M; Letvin NL; Chen ZW
J Virol; 2001 Sep; 75(18):8690-6. PubMed ID: 11507214
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simian/human immunodeficiency virus containing the K65R mutation in macaques.
Cong ME; Mitchell J; Sweeney E; Bachman S; Hanson DL; Heneine W; García-Lerma JG
J Infect Dis; 2013 Aug; 208(3):463-7. PubMed ID: 23633402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
